Table 6.
Clinical DDI | ||||
---|---|---|---|---|
Prediction | Predicted DDI | ≤2 | >2 | Total |
Chemical Inhibitors | ≤2 | 2 | 1 | 3 |
>2 | 3 | 10 | 13 | |
Total | 5 | 11 | 16 | |
GENTEST Vmax ISEF | ≤2 | 5 | 0 | 5 |
>2 | 3 | 12 | 15 | |
Total | 8 | 12 | 20 | |
PANVERA Vmax ISEF | ≤2 | 4 | 0 | 4 |
>2 | 4 | 12 | 16 | |
Total | 8 | 12 | 20 | |
PANVERA CLint ISEF | ≤2 | 4 | 0 | 4 |
>2 | 4 | 12 | 16 | |
Total | 8 | 12 | 20 |
Shaded boxes represent number of compounds where predicted DDIs were correctly categorized with the clinical DDIs.